|
1
|
Abrey LE, Batchelor TT, Ferreri AJ,
Gospodarowicz M, Pulczynski EJ, Zucca E, Smith JR, Korfel A,
Soussain C, DeAngelis LM, et al: Report of an international
workshop to standardize baseline evaluation and response criteria
for primary CNS lymphoma. J Clin Oncol. 23:pp. 5034–5043. 2005,
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan CC, Rubenstein JL, Coupland SE, Davis
JL, Harbour JW, Johnston PB, Cassoux N, Touitou V, Smith JR,
Batchelor TT, et al: Primary vitreoretinal lymphoma: A report from
an international primary central nervous system lymphoma
collaborative group symposium. Oncologist. 16:1589–1599. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peterson K, Gordon KB, Heinemann MH and
DeAngelis LM: The clinical spectrum of ocular lymphoma. Cancer-Am
Cancer Soc. 72:843–849. 1993.
|
|
4
|
Nussenblatt RB, Chan CC, Wilson WH,
Hochman J and Gottesman M: International Central Nervous System and
Ocular Lymphoma Workshop: Recommendations for the future. Ocul
Immunol Inflamm. 14:139–144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sung CO, Kim SC, Karnan S, Karube K, Shin
HJ, Nam DH, Suh YL, Kim SH, Kim JY, Kim SJ, et al: Genomic
profiling combined with gene expression profiling in primary
central nervous system lymphoma. Blood. 117:1291–1300. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim MM, Dabaja BS, Medeiros J, Kim S,
Allen P, Chevez-Barrios P, Gombos DS and Fowler N: Survival
outcomes of primary intraocular lymphoma: A single-institution
experience. Am J Clin Oncol. 39:109–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang L, Sato-Otsubo A, Sugita S, Takase H,
Mochizuki M, Usui Y, Goto H, Koyama T, Akiyama H, Miura O, et al:
High-resolution genomic copy number profiling of primary
intraocular lymphoma by single nucleotide polymorphism microarrays.
Cancer Sci. 105:592–599. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mulay K, Narula R and Honavar SG: Primary
vitreoretinal lymphoma. Indian J Ophthalmol. 63:180–186. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Witmer MT: Primary vitreoretinal lymphoma:
Management of isolated ocular disease. Cancer Control. 23:110–116.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stubiger N, Kakkassery V, Gundlach E,
Winterhalter S and Pleyer U: Diagnostics and treatment of primary
vitreoretinal lymphoma. Ophthalmologe. 112:223–230. 2015.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rajagopal R and Harbour JW: Diagnostic
testing and treatment choices in primary vitreoretinal lymphoma.
Retina. 31:435–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho BJ, Kim DY, Park UC, Lee JY, Yoon YH
and Yu HG: Clinical features and treatment outcomes of
vitreoretinal lymphoma according to its association with CNS
lymphoma. Ocul Immunol Inflamm. 26:365–371. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ahle G, Touitou V, Cassoux N, Bouyon M,
Humbrecht C, Oesterlé H, Baraniskin A, Soussain C, Nguyen-Them L,
Gaultier C, et al: Optic nerve infiltration in primary central
nervous system lymphoma. Jama Neurol. 74:1368–1373. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grimm SA, McCannel CA, Omuro AM, Ferreri
AJ, Blay JY, Neuwelt EA, Siegal T, Batchelor T, Jahnke K, Shenkier
TN, et al: Primary CNS lymphoma with intraocular involvement:
International PCNSL Collaborative Group Report. Neurology. 71:pp.
1355–1360. 2008, View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kreher S, Strehlow F, Martus P, Roth P,
Hertenstein B, Röth A, Birnbaum T, Griesinger F, Rauch M, Kanz L,
et al: Prognostic impact of intraocular involvement in primary CNS
lymphoma: Experience from the G-PCNSL-SG1 trial. Ann Hematol.
94:409–414. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jahnke K, Korfel A, Komm J, Bechrakis NE,
Stein H, Thiel E and Coupland SE: Intraocular lymphoma 2000–2005:
Results of a retrospective multicentre trial. Graefes Arch Clin Exp
Ophthalmol. 244:663–669. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaburaki T, Taoka K, Matsuda J, Yamashita
H, Matsuda I, Tsuji H, Tanaka R, Nakazaki K, Nakamura F, Kamiya K,
et al: Combined intravitreal methotrexate and immunochemotherapy
followed by reduced-dose whole-brain radiotherapy for newly
diagnosed B-cell primary intraocular lymphoma. Br J Haematol.
179:246–255. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Langner-Lemercier S, Houillier C, Soussain
C, Ghesquières H, Chinot O, Taillandier L, Soubeyran P, Lamy T,
Morschhauser F, Benouaich-Amiel A, et al: Primary CNS lymphoma at
first relapse/progression: Characteristics, management, and outcome
of 256 patients from the French LOC network. Neuro Oncol.
18:1297–1303. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nayak L, Hedvat C, Rosenblum MK, Abrey LE
and DeAngelis LM: Late relapse in primary central nervous system
lymphoma: Clonal persistence. Neuro Oncol. 13:525–529. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim JE, Yoon DH, Kim S, Lee DH, Kim JH,
Yoon YH, Chi HS, Lee SW, Park CS, Huh J and Suh C: Relapse pattern
and prognostic factors for patients with primary central nervous
system lymphoma. Korean J Hematol. 47:60–66. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferreri AJ, Blay JY, Reni M, Pasini F,
Gubkin A, Tirelli U, Calderoni A, Zucca E, Cortelazzo S, Chassagne
C, et al: Relevance of intraocular involvement in the management of
primary central nervous system lymphomas. Ann Oncol. 13:531–538.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fend F, Ferreri AJ and Coupland SE: How we
diagnose and treat vitreoretinal lymphoma. Br J Haematol.
173:680–692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coupland SE, Bechrakis NE, Anastassiou G,
Foerster AM, Heiligenhaus A, Pleyer U, Hummel M and Stein H:
Evaluation of vitrectomy specimens and chorioretinal biopsies in
the diagnosis of primary intraocular lymphoma in patients with
Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 241:860–870.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sugita S, Takase H, Sugamoto Y, Arai A,
Miura O and Mochizuki M: Diagnosis of intraocular lymphoma by
polymerase chain reaction analysis and cytokine profiling of the
vitreous fluid. JPN J Ophthalmol. 53:209–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chan CC, Whitcup SM, Solomon D and
Nussenblatt RB: Interleukin-10 in the vitreous of patients with
primary intraocular lymphoma. Am J Ophthalmol. 120:671–673. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cho BJ and Yu HG: Risk factors for
intraocular involvement in patients with primary central nervous
system lymphoma. J Neurooncol. 120:523–529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Akiyama H, Takase H, Kubo F, Miki T,
Yamamoto M, Tomita M, Mochizuki M, Miura O and Arai A: High-dose
methotrexate following intravitreal methotrexate administration in
preventing central nervous system involvement of primary
intraocular lymphoma. Cancer Sci. 107:1458–1464. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frenkel S, Hendler K, Siegal T, Shalom E
and Pe'Er J: Intravitreal methotrexate for treating vitreoretinal
lymphoma: 10 years of experience. Br J Ophthalmol. 92:383–388.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Isobe K, Ejima Y, Tokumaru S, Shikama N,
Suzuki G, Takemoto M, Tsuchida E, Nomura M, Shibamoto Y and
Hayabuchi N: Treatment of primary intraocular lymphoma with
radiation therapy: A multi-institutional survey in Japan. Leuk
Lymphoma. 47:1800–1805. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tropinskaya OF, Vetlova ER, Serova NK,
Golanov AV and Fil'Chenkova NA: Radiotherapy of primary intraocular
lymphoma associated with primary central nervous system lymphoma.
Zh Vopr Neirokhir Im N N Burdenko. 80:74–81. 2016.(In English,
Russian). View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Berenbom A, Davila RM, Lin HS and Harbour
JW: Treatment outcomes for primary intraocular lymphoma:
Implications for external beam radiotherapy. Eye. 21:1198–1201.
2007. View Article : Google Scholar : PubMed/NCBI
|
